Largest biotech companies by market cap: 55 companies with a combined market value of $855.71 B. Amgen Inc. (AMGN) leads at $196.87 B. Biological product and biotechnology research companies ranked by market value. Rankings update as fresh market data lands; click any company for its financial statements, charts, and SEC filing history.
| Rank | Company | Industry | Market Cap |
|---|---|---|---|
| 1 | Biological Products, (No Diagnostic Substances) | $196.87 B | |
| 2 | Biological Products, (No Diagnostic Substances) | $166.58 B | |
| 3 | Aargenx SEARGX | Biological Products, (No Diagnostic Substances) | $56.26 B |
| 4 | RRevolution Medicines, Inc.RVMD | Biological Products, (No Diagnostic Substances) | $41.02 B |
| 5 | Services-Commercial Physical & Biological Research | $34.91 B | |
| 6 | Biological Products, (No Diagnostic Substances) | $30.06 B | |
| 7 | Biological Products, (No Diagnostic Substances) | $29.50 B | |
| 8 | Services-Commercial Physical & Biological Research | $23.72 B | |
| 9 | Biological Products, (No Diagnostic Substances) | $23.64 B | |
| 10 | Biological Products, (No Diagnostic Substances) | $17.94 B | |
| 11 | Services-Commercial Physical & Biological Research | $15.24 B | |
| 12 | Biological Products, (No Diagnostic Substances) | $14.28 B | |
| 13 | IICON Public Limited CompanyICLR | Services-Commercial Physical & Biological Research | $12.79 B |
| 14 | Biological Products, (No Diagnostic Substances) | $11.14 B | |
| 15 | Services-Commercial Physical & Biological Research | $11.13 B | |
| 16 | Biological Products, (No Diagnostic Substances) | $10.83 B | |
| 17 | AApogee Therapeutics, Inc.APGE | Biological Products, (No Diagnostic Substances) | $9.99 B |
| 18 | Biological Products, (No Diagnostic Substances) | $9.53 B | |
| 19 | Biological Products, (No Diagnostic Substances) | $9.39 B | |
| 20 | IImmunityBio, Inc.IBRX | Biological Products, (No Diagnostic Substances) | $9.11 B |
| 21 | Biological Products, (No Diagnostic Substances) | $9.04 B | |
| 22 | PVaxcyte, Inc.PCVX | Biological Products, (No Diagnostic Substances) | $8.56 B |
| 23 | IImmunovant, Inc.IMVT | Biological Products, (No Diagnostic Substances) | $8.40 B |
| 24 | Biological Products, (No Diagnostic Substances) | $8.09 B | |
| 25 | SScholar Rock Holding CorporationSRRK | Biological Products, (No Diagnostic Substances) | $6.87 B |
| 26 | AArcellxACLX | Biological Products, (No Diagnostic Substances) | $6.73 B |
| 27 | CCG Oncology, Inc.CGON | Biological Products, (No Diagnostic Substances) | $6.48 B |
| 28 | Biological Products, (No Diagnostic Substances) | $5.91 B | |
| 29 | Biological Products, (No Diagnostic Substances) | $5.52 B | |
| 30 | DDenali Therapeutics Inc.DNLI | Biological Products, (No Diagnostic Substances) | $4.26 B |
| 31 | Biological Products, (No Diagnostic Substances) | $3.92 B | |
| 32 | Biological Products, (No Diagnostic Substances) | $3.76 B | |
| 33 | Biological Products, (No Diagnostic Substances) | $3.49 B | |
| 34 | Biological Products, (No Diagnostic Substances) | $2.76 B | |
| 35 | TTarsus Pharmaceuticals, Inc.TARS | Biological Products, (No Diagnostic Substances) | $2.74 B |
| 36 | KKodiak Sciences Inc.KOD | Biological Products, (No Diagnostic Substances) | $2.51 B |
| 37 | Biological Products, (No Diagnostic Substances) | $2.45 B | |
| 38 | AADMA Biologics, Inc.ADMA | Biological Products, (No Diagnostic Substances) | $2.12 B |
| 39 | Biological Products, (No Diagnostic Substances) | $2.07 B | |
| 40 | Biological Products, (No Diagnostic Substances) | $2.02 B | |
| 41 | Biological Products, (No Diagnostic Substances) | $1.99 B | |
| 42 | Biological Products, (No Diagnostic Substances) | $1.99 B | |
| 43 | TTaysha Gene Therapies, Inc.TSHA | Biological Products, (No Diagnostic Substances) | $1.85 B |
| 44 | Biological Products, (No Diagnostic Substances) | $1.82 B | |
| 45 | MMaze Therapeutics, Inc.MAZE | Biological Products, (No Diagnostic Substances) | $1.80 B |
| 46 | AAbsci CorporationABSI | Services-Commercial Physical & Biological Research | $1.79 B |
| 47 | VVir Biotechnology, Inc.VIR | Biological Products, (No Diagnostic Substances) | $1.75 B |
| 48 | CHemab Therapeutics Holdings, Inc.COAG | Biological Products, (No Diagnostic Substances) | $1.74 B |
| 49 | IImmunocore Holdings plcIMCR | Biological Products, (No Diagnostic Substances) | $1.68 B |
| 50 | Biological Products, (No Diagnostic Substances) | $1.54 B | |
| 51 | IInhibrx Biosciences, Inc.INBX | Biological Products, (No Diagnostic Substances) | $1.53 B |
| 52 | Biological Products, (No Diagnostic Substances) | $1.32 B | |
| 53 | Biological Products, (No Diagnostic Substances) | $1.12 B | |
| 54 | Biological Products, (No Diagnostic Substances) | $1.11 B | |
| 55 | AAlvotechALVO | Biological Products, (No Diagnostic Substances) | $1.04 B |
Industry membership comes from each company's SEC-registered SIC classification, parsed from EDGAR submissions. Market capitalizations refresh continuously from cached market data combined with SEC-reported share counts. See the full market cap rankings or the IPO filings tracker.